Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

REN > Week 6 > Flashcards

Week 6 Flashcards

(87 cards)

Start Studying
1
Q

Functions of the kidneys

A

Homeostasis:
-water/fluid
-electrolytes
-acid-base
-blood pressure
-elimination of waste
-excretion of drugs and drug metabolites
Metabolic/endocrine:
-synthesis of hormones
— vitamin D
— erythropoietin
—renin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Measurement of glomerular filtration rate

A

Gold standards but not used clinically
Exogenous filtration markers:
-e.g inulin, 51Cr-EDTA
-require injection or infusion
-require multiple sample collection
-cumbersome, intrusive
Endogenous filtration markers:
-eg urinary clearance of creatinine
-requires accurate timed urine collection and matched serum sample
-cumbersome and error prone

Only used rarely for specific purposes when clinical decisions depend on accurate knowledge of GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Estimation of GFR from serum creatinine

A

Creatinine from breakdown of muscle and gets cleared by kidneys
Limitation 1:
-Non linear relationship between serum creatinine and GFR. Small changes in serum creatinine value can mean large changes in GFR
Non renal determinants of serum creatinine include:
-age
-sex
-ethnicity
-body habitus
-diet
Limitation 2:
-creatinine is an end product of muscle turnover, creatinine generation is proportional to muscle mass
-creatinine can also be derived from dietary meat or creatinine supplements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Quantification of proteinuria

A

Injured, inflamed or damaged glomerulus/kidneys will leak protein
Bad prognostic factor in terms of progression of cKD, increase risk CVD and mortality
Concentration of any analyte in urine is heavily influenced by concentration or urine
Measure total amount: protein excretion in 24 hrs urine sample
Measure ratio to reference analyte (known conc.): protein:creatinine ratio or albumin:creatinine ratio to estimate protein in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Definition of chronic kidney disease

A

CKD is defined as abnormalities of kidney structure or function, present for> 3 months with implications for health
Albuminuria
Urine sediment abnormalities- blood or RBC casts
Structural abnormalities etc
Decreased GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Classification of CKD

A

Stage 1: normal kidney function GFR>90ml/min but proteinuria or blood etc
When estimating GFR with creatinine cant go up to 120 as EGFR increases confidence of measurement decreases
Moderate stage 3A 3B- CKD with reduced renal function
Severe stage 5 GFR<15
Irreversible loss of renal filtration function (loss of nephrons)
Progressive loss of renal filtration function if untreated irreversible damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Stage 5 CKD end stage renal failure

A

Insufficient renal function to sustain life/health
Haemodialysis, peritoneal dialysis
Kidney transplantation
Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Relative risks for adverse outcomes

A

Knowing if someone has proteinuria helps determine the cause
Helps narrow down investigations and find cause CKD, do biopsy because we’re looking to see the type of inflammatory disease so can treat appropriately
Proteinuria increases rate at which CKD progresses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Who has renal disease

A

Common with Uk population
Significant proportion unrecognised
Important risk factors are:
-age
-social deprivation
-black or south Asian ethnicity
-hypertension
-diabetes
-smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of CKD

A

Diabetes- diabetic kidney disease
Hypertension/ischaemic
Glomerulonephritis
Genetic
Other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diabetic nephropathy

A

Diabetic kidney disease
Renal disease occur 40% patients with type I and 2 diabetes
40% patients with ESRF in US and 20% in Europe
Associated with poor diabetes control and hypertension
Characterised by proteinuria
Correlation with diabetic retinopathy
If you have microvascular disease elsewhere likely to get it in kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathology of diabetic nephropathy

A

Thickening of basement membrane
Mesangial expansion . Get collagen deposits and fibrosis
-hyperglycaemia stimulates increased matrix production by mesangial cells
-stimulation of TGF-beta release
Glomerulosclerosis due to intraglomerular hypertension or ischaemic damage
Hyperglycaemia causes vasodilation of afferent arterioles increasing glomerular pressure (so people with diabetic KD at first hyperfiltrate slight increase in GFR) then causes damage with time starts to develop proteinuria and reduce kidney function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Natural history of diabetic nephropathy

A

Onset of diabetes:
-increased GFR
-reversible albuminuria
-increased kidney size
After ~5 years :
-increased glomerular basement membrane thickness
-mesangial expansion
Mircoalbuminuria and rising blood pressure
11-23 years: onset proteinuria
13-25 years: rising serum creatinine
15-27 years: ESRF
Inevitable decline in renal function over 7-10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment diabetic nephropathy

A

Treat underlying cause: good blood sugar control (diet and medications)
Reduce proteinuria: ACE inhibition and SGLT2 inhibitor
Limit cardiovascular risk: control blood pressure, treat hyperlipidaemia stop smoking etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hypertensive nephropathy

A

Vascular remodelling (atherosclerosis, intimal thickening) leading to narrowing of blood vessels and glomerular ischaemia
Glomerular hypertension causing injury and sclerosis over prolonged periods
Progressive kidney disease, progressive fibrosis
Thickened intima
Segmented sclerosis scarring glomeruli more lesions, more scarring nephrons, lose functional nephrons progressive CKD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Renovascular disease

A

Because of atherosclerosis can disrupt blood supply to kidneys
Renal artery stenosis
Likely to have hypertension and CVD cKD due to other reasons as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Glomerulonephritis

A

Immune mediated injury to glomeruli
Characteristic changes in kidney histology and immunohistochemistry
Typically blood and/or protein in urine
Immunocomplex formation and deposition in glomeruli that causes damage
Many different disease processes:
-e.g IgA nephropathy (most common)
-can be associated with infection (e.g streptococcus, HIV)
-can be part of systemic disease process (e.g systemic lupus erythematosus, vasculitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Autosomal dominant polycystic kidneys

A

Most common genetic cause
Autosomal dominant most common manifests in adulthood
There are recessive forms too that manifest in childhood
Large cysts, large kidneys, very painful. Cysts can rupture- painful can cause haematuria
Loss nephrons due to cysts displacing functional tissue
Affects ~1 in 1000 people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Other causes of CKD

A

-Medications (NSAIDs, chemotherapy, others)
-recurrent urinary tract infection
-urinary outflow obstruction- common, benign hyperplasia
-trauma uncommon
-interstitial nephritis
-recurrent/persistent acute kidney injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Complications related to CKD

A

Increased mortality, cardiovascular disease and hypertension. Altered drug handling
Anaemia, vitamin D, phosphate and parathyroid disturbance
Acidosis, hyperkalaemia
Fluid retention, uraemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cardiovascular risk in CKD

A

Traditional risks: diabetes, hypertension, dyslipidaemia, smoking
Non classical risks: endothelial dysfunction, inflammation, oxidative stress, catabolic state
CKD-related risks: fluid retention, anaemia, hyperparathyroidism, vascular calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Hypertension

A

Multiple mechanisms:
-sodium retention
-volume expansion
-renin-angiotensin-system activation
-sympathetic nervous system activation
-endothelial dysfunction
Accelerates decline of kidney function
Contributes to cardiovascular risk (stroke, myocardial infarction, heart failure)
Management:
-moderate salt intake
-RAS blockade
-diuretics
-other anti-hypertensive medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Vitamin D, calcium and parathyroid hormone in renal failure

A

Vitamin D not activated in kidneys
So serum calcium not increased
Constant secretion of PTH and bone resorption
Cycle repeats not corrected autonomous production PTH by parathyroid glands. Secondary and tertiary hyperparathyroidism
Major risk factor for calcium deposition in blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Renal bone disease

A

Brown tumour
Rugger jersey spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Ectopic calcification
Calcium depositions in blood vessels Risk factor of CVD
26
How to manage mineral bone disease
Correct global vitamin D deficiency if present (colecalciferol, ergocalciferol) Supplement activated vitamin D (Alfacalcidol, calcitriol) Control high phosphate levels (dietary restriction, phosphate binders) Offer calcimimetics -stop producing PTH Last resort: parathyroidectomy
27
Anaemia
Impact: -impaired quality of life —reduced exercise capacity —impaired cognition -increase risk of left ventricular hypertrophy -increase CV disease in patients with CKD and anaemia vs those with CKD without anaemia Management: -correct iron deficiency if present, helps RBC production -recombinant erythropoietin: supplement what kidneys cant produce stimulate bone marrow to produce RBCs
28
Bicarbonate- carbonic acid buffer system
PH= pK+logHCO3-/H2CO3- With progressive kidney disease you fail to excrete H+, reabsorb serum HCO3- and metabolic acidosis Increase CO2 removed by lungs to maintain pH
29
Metabolic acidosis
Impact: -increased respiratory rate -acute-life threatening metabolic dysfunction -chronic- loss of bone and muscle mass Management : - sodium bicarbonate -dialysis (or transplantation)
30
Hyperkalaemia
Enormous functional reserve to excrete potassium Severe hyperkalaemia when GFR<10ml.min Due to: -excessive load -interference with potassium excretion — acidosis with volume contraction — diabetic nephropathy Alterations in membrane excitability Cardiac arrhythmias ECG changes: -tall T waves - long QRS interval -long PR interval -cardiac arrest
31
How to manage hyperkalaemia
Input side: -dietary potassium restriction -potassium binders- dont use in clinical practice Output side: -dialysis (or transplantation) Determinants on when to start: -how patient feels- degree of uremia -losing weight, vomiting etc -EGFR<10ml/min
32
Sodium and fluid retention
Loss of nephrons reduces ability to excrete salt and water Major cause of hypertension and fluid overload Sodium must be within normal range for normal neurological function High or low sodium leads to confusion, fits and coma
33
Failure of fluid homeostasis
Inability to concentrate urine (early): -loss of diurnal rhythm of urine excretion Inability to excrete water load: -dilutional hyponatraemia -oedema- pitting oedema, painful -hypertension
34
How to manage fluid overload
Input side: -salt restriction -fluid restriction Output side: -diuretics -dialysis or transplant
35
Uraemia- accumulation of metabolic waste products
Accumulation of toxic waste products: -retention nitrogenous waste (urea) -numerous other known and unknown compounds (urate, phosphate, TNF-alpha, IL-6, p-crestless sulfate, beta2-microglobulin) Life threatening consequences of uraemia: -encephalopathy- metabolic flap- asterixis -pericarditis- cardiac tamponade
36
Retention of drugs and drug metabolites
Many drugs metabolised and or excreted by the kidney Consequences of impaired renal clearance: -prolonged duration of action -toxicity from high drug levels Insulin-> hypoglycaemia Opiates-> reduced consciousness and respiratory arrest Antibiotics-> encephalopathy Lithium-> vomiting, tremors, confusion Digoxin-> arrhythmia
37
Acute kidney injury
Sudden deterioration in kidney function Timing: hours, days, weeks has to be less than 3 months Spectrum: mild drop in renal function to complete loss of kidney function (kidney failure) May result in failure to maintain, fluid , electrolyte and acid base balance Formerly known as acute renal failure Differentiate from cKD
38
AKI staging
Stage 1: creatinine >26umol/L in 48 hours. Urine output <0.5ml/kg for >6 hrs Stage 2: 100-200% increase creatinine. Urine < 0.5 for >12 hrs Stage 3: >200% increase >357 creatinine. Urine <0.3ml/kg >24 hrs or Anuria for 12 hours. Needs dialysis
39
How common is acute kidney injury
AKI is present in: up to 1 in 5 emergency admissions into hospital have or develop AKI The incidence is increasing: improved detection, electronic alerts, increasing elderly population who are at risk Cost of AKI: accounts for 1 billion/year, 1% of NHS budget
40
Impact and importance
100000 deaths in hospital per year associated with AKI ~ 20% of these deaths could potentially be prevented with appropriate treatment and care 1 in 5 emergency admissions has AKI Community acquired versus hospital acquired Associated with very high mortality
41
AKI causes chronic kidney disease
Patients with AKI are more likely to develop ESRD Patients with AKI and CKD are even more likely to develop ESRD
42
Risk factors for AKI
Age> 65 years History of: -chronic kidney disease -diabetes -heart failure -liver disease Reliance on other for fluid intake Context: -sepsis -hypovolaemia -hypotension -dehydration -reduce fluid intake Drugs: -diuretics, ACE inhibitors/ARBs, blood pressure medication, metformin, NSAIDs, gentamicin, acyclovir, contrast
43
Causes of AKI
Pre-renal: perfusion failure Intrinsic: intrinsic disease of the kidney Post-renal: obstruction of urinary system
44
Pre-Renal causes
Hypovolaemia: eg dehydration, gastrointestinal losses, haemorrhage, burns Hypotension: eg sepsis Renal artery occlusion Hypervolaemic states associated with reduced renal perfusion: heart failure, liver failure Drugs that reduce BP, circulating volume or renal blood flow e.g ACE inhibitors, NSAIDs, diuretics, antihypertensives
45
Renal autoregulation
Afferent and efferent arteriole vasoconstrict and vasodilate controlling flow through kidney
46
Perfusion failure
Low BP and low blood volume kidney responds by afferent dilation good perfusion and urine production But if very low BP and very low blood volume, very low renal perfusion and very low urine production= pre renal failure/ perfusion failure In context of low blood pressure due to ACE/ARB block renin angiotensin system RAS blockade, lose afferent dilation and efferent constriction, low blood flow, cant perfuse glomerulus properly, lack of urine production
47
Treatment of perfusion failure
Restore tissue perfusion: -fluid volume replacement —blood, IV fluids -blood pressure support (inotropic drugs) -restore arterial patency -stop exacerbating drugs —RAS blockade —stop NSAID
48
Obstruction POST renal
Benign prostatic hypertrophy most common Tumours: -intrinsic eg bladder, ureter -extrinsic e.g prostate, cervix Fibrosis Stones- rare to have bilateral so not most common
49
Treating obstruction- unblocking the pipes
Nephrostomy Bladder catheter Urinary stent
50
Renal causes
Diseases that damage the tubules, interstitium, glomeruli -acute tubular necrosis most common -acute interstitial nephritis -drugs: antibiotics, NSAID, chemotherapy -infection: HIV, hepatitis B/C, post-streptococcal, endocarditis, COVID-19 -systemic disease: vasculitis, lupus, myeloma -glomerulonephritis (blood an or protein present on urine dipstick)
51
Nephrotic syndrome
Complete loss filtration barrier Leak lots protein Hypoalbuminaemic Lose oncotic pressure so get oedema Present with oedema, low albumin in blood, protein in urine No cellular proliferation Insidious onset
52
Nephritic syndrome
Inflammatory disease in kidneys typically presents with rapidly progressive glomerulonephritis Blood/protein in urine Less protein than nephrotic syndrome More inflammation, rapid reduction in kidney function Cellular proliferation and immune complex deposition Abrupt onset
53
Causes of death
Infection Other underlying disease: eg cancer, cardiovascular diabetes Hyperkalaemia Acidosis Pulmonary oedema These can be managed by dialysis, potassium lowering drugs
54
Prevention, assessment, management
Identify those at risk of AKI early -patient related risk factors -admission related risk factors -intervention/treatment related risk factors Monitoring: -urine output -input/output -weights Management: -starts with identification and recognition of AKI risk -fluid balance -fluid intervention oral and iV -exclude obstruction -urine dipstick -treatment of underlying problems -stopping Nephrotoxic drugs and context specific drugs -ongoing monitoring and treatment adjustment -ongoing monitoring and fluid intervention adjustments -referral
55
Dialysis
Indications: -fluid overload -hyperkalaemia -severe metabolic acidosis -severe uraemia Unresponsive to medical management Removal of poisons/toxins
56
What is renal replacement therapy RRT
Life supporting treatment for renal failure -acute vs chronic Dialysis: -haemodialysis -peritoneal dialysis Transplantation
57
What do kidneys do
Filtration and excretion -electrolyte balance, fluid balance, acid-base balance BP regulation Regulation of RBC production Vitamin D activation
58
When is RRT necessary
Failure to perform filtration/excretion functions-> potentially life threatening consequences Chronic kidney disease stage 5 -Irreversible damage to the kidneys, requiring long term life sustaining therapy Acute kidney injury -Severe, potentially reversible, kidney “shut down” -temporary life sustaining therapy
59
Important emergency RRT indications
Hyperkalaemia- resistant to treatment Severe pulmonary oedema- resistant to treatment Severe acidosis- resistant to treatment Severe uraemia- pericarditis, seizures Ingestion of dialysable poisons eg ethylene glycol
60
What can RRT replace
Dialysis: filtration and excretion: electrolyte balance, fluid balance, acid-base balance. Only to GFR 15ml/min Transplantation: filtration and excretion, BP regulation, regulation of RBC production, vitamin D activation
61
What is dialysis
Separation/movement of particles in a liquid based on their ability to pass through a semipermeable membrane Membranes used in dialysis: -synthetic e.g. polysulfone can vary size of pores -biological eg peritoneum, peritoneal dialysis, can’t alter membrane, people differ in composition Use different types of forces to enable clearance of small and bigger solutes to enable clearance of fluids Can add buffers e.g lactate that buffers H+ to correct acidosis
62
How do particles move across the membrane
Diffusion- solvent moves by concentration gradient Ultrafiltration- solution moves by pressure gradient Can apply hydrostatic pressure to one side semi permeable membrane so water moves across membrane Osmosis- water moves by concentration gradient, peritoneal dialysis Can also have convection, solute drag, small solutes move across with fluid if the fluid is moving with high flow rate can eliminate small solutes effectively e.g urea. Used in haemodialysis
63
Haemodialysis
Intermittent: 4 hours 3x a week, outpatient Extracorporeal (outside the body) Hospital/outpatient, some dialyse at home (need right water treatment) RRT of choice is usually haemofiltration continuous dialysis at slower flow rate which if you have haemodynamic instability is more gentle Diffusion, ultrafiltration and convection Lots of fibres increase surface area
64
Countercurrent gradient
Blood travels on one side of dialysis membrane Dialysis fluid passes on other side of dialysis membrane
65
Haemodialysis can change membrane pore size
E.g high flux dialysers-> large pores, enhanced middle molecule clearance
66
What do you need for haemodialysis
Patient Access to blood Dialyser Dialysis machine Ultra-pure water Dialysis nurse
67
Access to blood haemodialysis
Acute setting: temporary dialysis catheter/vascath, NB: clotting Chronic setting: long term dialysis catheter/tunnelled line, arterio-venous fistula/graft
68
AV fistula and AV graft
AV fistula: anastomose vein and artery, vein gets arterialised gets bigger and tougher wall so dialysis needles dont collapse the vein. Radial A to cephalic vein, brachial A to cephalic vein, brachial A to basilic vein AV graft: synthetic material connecting artery to vein, can needle the graft, clots eventually, fistula better
69
Ultrapure water
Free from: -chlorine -heavy metals -XS Mg/Ca -endotoxins -bacteria
70
Dialysis nurse
Machine set up Patient connection Monitoring Troubleshooting Patient disconnection Crucial
71
Peritoneal dialysis
Continuous therapy Corporeal (inside body) Semi permeable membrane- peritoneum Home therapy Diffusion, osmosis, convection Membrane pores: individual variability, cant predict or change Aquaporins- water movement
72
Peritoneal dialysis fluid
“Iatrogenic ascites” Carried out in peritoneal space Fluid: -hypertonic -> osmotic gradient : — glucose —starches e,g icodextrin, cant equilibrate so water only moves in one direction -diffusion gradient: K+, Na+, urea -acid/base: lactate
73
Dialysis and acid-base
Blood [H+]= low (freely diffuses into tissues) Can’t remove acid load by filtration alone Alkali added to patient from dialysis solution: - concentration of alkali is greater than in plasma -lactate, acetate, bicarbonate -lactate and acetate metabolised to CO2 and H2O and H+ consumed and buffer generated -in CAPD lactate used as buffer metabolised in Krebs cycle to pyruvate
74
CAPD and APD
CAPD: continuous ambulatory peritoneal dialysis - manual exchanges eg 2-3L 4x daily, 3 a day one at night APD: automated peritoneal dialysis -intermittent overnight -6-8 hours 4-6 fill/drain cycles
75
Considerations for peritoneal dialysis
Age, older age more frail, lose vision and dexterity so may not be able to do dialysis themselves, assisted peritoneal dialysis Previous abdominal surgeries/stomas Polycystic kidney disease- space considerations Home: -water source next to bedroom, hand washing prevent infections -storage for fluid
76
HD vs PD
Equally effective Patient choice HD: short intermittent treatment time, hospital therapy, defined fluid removal. Access complications, lifestyle disruption, holiday considerations, stricter diet, muscle cramps/fatigue, haemodynamic instability PD: continuous/daily treatment gentle clearance, less haemodynamic instability, home therapy, more liberal diet, holiday flexibility. Access peritonitis risk, peritoneal sclerosis, membrane failure risk, home storage of kit
77
Problems with dialysis HD
Access: -clotting -central venous stenosis -infection- lines >>AVF: —bacteraemia —endocarditis —osteomyelitis/discitis Haemodynamic instability Fatigue
78
Problems with dialysis PD
PD tube dysfunction: -constipation -migration -occlusion e.g fibrin Infection: -peritonitis- cloudy fluid -gram +ve>-ve Membrane failure Encapsulating peritoneal sclerosis EPS
79
The biggest problem with dialysis
20% patients will die each year Cardiac disease: -LVH due to hypertension, anaemia, fluid overload -calcification of arteries, lipid abnormalities Infection (secondary immunodeficiency) Anaemia Bone disease Malnutrition NB. Conservative management is a treatment option for ESRF
80
Transplantation
Treatment of choice for ESRF Improved QOL, improved survival Recovery of renal function, including EPO and vitamin D production Iliac fossa insert ureter into bladder and blood supply into aorta Discuss with all patients unless absolute contraindications present Live donor- careful assessment Deceased donor - waiting list Timing: pre-emptive= better outcomes, limited by donor pool
81
Assessment of potential transplant recipient
Age Age-related comorbidity: frailty scoring Cardiovascular risk Immunosuppression risk- malignancy (2-5 years remission) Surgical factors: -BMI>30 challenging operative perspective and bone closure perspective -vascular anatomy and intraabdominal space PKD Immunological factors-> previous sensitisation ?ABOi Patient needs to be fit for major surgery and chronic immunosuppression
82
Contraindications of transplants
Absolute contraindications: -high peri-operative mortality -poor life expectancy -active malignancy Relative contraindications: -coronary or cerebrovascular disease -recurrent disease -non compliance
83
Transplant complications
Early/medium term: -CV morbidity/mortality -infection -rejection Long term: additional -increased CVD risk -Tx-associated DM -opportunistic infections/viral reactivation -malignancy esp non-melanoma skin cancer and virus associated eg PTLD (EBV)
84
Transplant immunology
Donor and recipient must be matched: -species -blood group antigens (ABO)- not always possible to desensitise -HLA antigens: class I A/B, class II DR Reduce alloimmune responses (detection of non-self)
85
Matching HLA antigens
Tissue typing -> analysis of recipient HLA types (blood- leukocytes) Pre-existing anti HLA antibodies-> calculated reaction frequency cRF%: -testing recipient serum against panel of common HLA antigens -identifies ‘highly sensitised’ patients-> pregnancy, transfusions, previous transplants Crossmatching: done just before transplant: -identifies recipient pre formed Abs against specific donor antigens -‘virtual’- recipient serum reactivity against donors known HLA alleles (BEAD assay) -‘wet’ or ‘leukocyte’ cross match- recipient serum reactivity against donor leukocytes CELL assay
86
Immunosuppression
Required even if ‘well matched’ Up to 30-40% may still reject but treatable Main goal is to reduce T cell alloimmune responses- reduce ability of T cells to mount effective responses to non self antigens, increase infection risk, decrease ability to fight off infection, increase risk cancer Induction v maintenance Triple therapy: -CNI (calcineurin inhibitors) eg tacrolimus -antiproliferative agents eg mycophenolate MMF, azathioprine -corticosteroids- prednisolone Basiliximab (induction)- anti CD25 (IL-2Ra)
87
Induction immunosuppression considerations
Infection risk: -CMV-> valganciclovir -fungi/oral thrush -> nystatin -pneumocystis-> co-trimoxazole High dose steroids: -GI protection-> PPI -bone protection-> calcium supplementation

REN (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions